PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise Associates Newly appointed board and ...

BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Friday reported a loss of $25.7 million in its second quarter. On a per-share basis, the Boston-based company said it had a loss of $3.47 ...

New drug developer Boston Pharmaceuticals has secured a $600 million commitment from Gurnet Point Capital. In addition to the financing, Christopher Viehbacher, a managing partner of Gurnet Point ...

Boston Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting New Phase 2 Clinical Data from BOS-580 NASH Program at EASL 2023 May 18, 2023 07:00 AM Eastern Daylight Time ...

Boston Pharmaceuticals To Present New Phase 2a Data From Investigational BOS-580 NASH Program at AASLD The Liver Meeting® 2023 November 07, 2023 09:44 AM Eastern Standard Time ...

BOSTON, June 9, 2025 – The Renaissance Boston Seaport District recently debuted its stunning new rooms… Scouting America is proud to announce that Bob Rivers, Executive Chair and Chair of the ...

Boston Pharmaceuticals is launching with $600 million. Led by the former CEO of Sanofi, the company's focused on developing drugs ready to enter the clinic.

BOSTON (AP) — BOSTON (AP) — Ironwood Pharmaceuticals Inc. (IRWD) on Thursday reported second-quarter profit of $23.6 million. On a per-share basis, the Boston-based company said it had net income of ...

Boston Pharmaceuticals today announces the appointment of Joanne Beck, Ph.D., as Chief Operating Officer. Dr. Beck joins Boston Pharmaceuticals from Celgene Corporation, where she was Executive ...

Novartis AG (NOVN.EB) said Wednesday that it entered into a licensing and equity agreement with Boston Pharmaceuticals to develop three anti-infective drug candidates that are part of the Swiss ...